Plasmodium falciparum is partially mediated through binding of malaria-speciWc IgG to Fc gamma ( ) receptors. Variations in human Fc RIIA-H/R-131 and Fc RIIIB-NA1/NA2 aVect diVerential binding of IgG sub-classes. Since variability in Fc R may play an important role in severe malarial anemia (SMA) pathogenesis by mediating phagocytosis of red blood cells and triggering cytokine production, the relationship between Fc RIIA-H/R131 and Fc RIIIB-NA1/NA2 haplotypes and susceptibility to SMA (Hb < 6.0 g/dL) was investigated in Kenyan children (n = 528) with acute malaria residing in a holoendemic P. falciparum transmission region. In addition, the association between carriage of the haplotypes and repeated episodes of SMA and all-cause mortality were investigated over a 3-year follow-up period. Since variability in Fc R can alter interferon (IFN)-production, a mediator of innate and adaptive immune responses, functional associations between the haplotypes and IFN-were also explored. During acute malaria, children with SMA had elevated peripheral IFN-levels (P = 0.006). Although multivariate logistic regression analyses (controlling for covariates) revealed no associations between the Fc R haplotypes and susceptibility to SMA during acute infection, the Fc RIIA-131H/ Fc RIIIB-NA1 haplotype was associated with decreased peripheral IFN-(P = 0.046). Longitudinal analyses showed that carriage of the Fc RIIA-131H/Fc RIIIB-NA1 haplotype was associated with reduced risk of SMA (RR 0.65,; P = 0.012) and all-cause mortality (P = 0.002). In contrast, carriers of the Fc RIIA-131H/ Fc RIIIB-NA2 haplotype had increased susceptibility to SMA (RR 1.47, 95% CI 1.06-2.04; P = 0.020). Results here demonstrate that variation in the Fc R gene alters susceptibility to repeated episodes of SMA and mortality, as well as functional changes in IFN-production.
Introduction
Plasmodium falciparum malaria remains one of the most common causes of morbidity and mortality in African children with severe manifestations of disease deWned by the following clinical sequeleae: high-density parasitemia (HDP ¸10,000 parasites/ L); hypoglycemia; severe malarial anemia [SMA; hemoglobin (Hb) <6.0 g/dL]; cerebral malaria (CM); and respiratory distress (Bloland et al. 1999b; English et al. 1998; Mockenhaupt et al. 2004; Ong'echa et al. 2006) . Naturally acquired antibodies are important for protection against asexual blood stages of malaria as evidenced by passive transfer of immunoglobulin G (IgG) from malaria-immune adults to malaria-naive children (Sabchareon et al. 1991) . Binding of the heavy chain immunoglobulin domain to Fc receptors on phagocytic cells is important for protective immunity against malaria (Sabchareon et al. 1991) . Fc gamma receptors IIA (Fc RIIA) and Fc RIIIB are low-aYnity Fc -receptors expressed on monocytes/macrophages, and other immune cells, that interact with complex (or aggregated) IgG subtypes (IgG 1-4 ) (Stein et al. 2000) , thereby providing an important link between cellular and humoral malarial immunity.
Fc RIIA has co-dominantly expressed allotypes, diVering by one amino acid (histidine or arginine) at position 131 (Fc RIIA-131H/R). A previous study in a holoendemic P. falciparum transmission area of western Kenya illustrated that the R/R131 genotype, that preferentially binds IgG 1 and IgG 3 (Bouharoun-Tayoun et al. 1995) , was associated with protection against intermediate levels of parasitemia (i.e., >5,000 parasites/ L) relative to the H/R131 genotype (Shi et al. 2001 ). In addition, our previous investigation in an adjacent region demonstrated that the R/R131 genotype was signiWcantly associated with protection against HDP (¸10,000 parasites/ L) . Studies in The Gambia also showed that homozygous H131 alleles, with preferential binding to IgG 2 (Warmerdam et al. 1991) , increased susceptibility to malaria in children with a mixed clinical phenotype of severe disease characterized by CM, SMA, and/or hypoglycemia (Cooke et al. 2003) .
Fc RIIIB is constitutively expressed on neutrophils with two of the allelic forms (NA1 and NA2) diVering at four amino acid positions, including two potential glycosylation sites. Expression of Fc RIIIB-NA1/NA2 inXuences the phagocytic capacity of neutrophils as evidenced by studies showing that the Fc RIIIB-NA2/NA2 genotype was associated with reduced phagocytosis relative to homozygous Fc RIIIB-NA1 (Salmon et al. 1990 ). Haplotypic studies in Thai adults further revealed that co-carriage of the Fc RI-IIB-NA2 and Fc RIIA-HH131 alleles increased susceptibility to CM (Omi et al. 2002) . However, the association between these haplotypes and susceptibility to severe malaria in holoendemic P. falciparum transmission areas has not been previously reported.
Interferon-gamma (IFN-) is a multifunctional cytokine produced primarily from T lymphocytes and natural killer (NK)-cells, which plays an important role in modulating the immune response (Miller et al. 2009 ). Based on the fact that IFN-is associated with development of a type 1 (cellmediated) immune response, this cytokine forms an integral part of innate immunity (Gajewski et al. 1989; Chehimi and Trinchieri 1994; Kobayashi et al. 2000) . A previous study showed that higher malaria-speciWc production of IFNand elevated anti-malarial IgG and IgE were associated with protection against malaria in West African populations (Farouk et al. 2005) . Recent investigations in Thai adults also demonstrated signiWcant diVerences in IFN-levels between patients with complicated and uncomplicated malaria (Tangteerawatana et al. 2007 ).
Since elevated IFN-production is associated with reduced levels of P. falciparum parasitemia (Torre et al. 2002b) , along with data showing that IFN-bridges innate and adaptive immunity through engagement of immunoglobulins (Janeway and Medzhitov 2002) , we reasoned that variability in Fc RIIA and Fc RIIIB may condition susceptibility to severe malaria by altering the production of IFN-. Our previous investigations in the cohort investigated here demonstrated that multi-site haplotypes are highly informative allelic markers that can reveal associations with malaria disease outcomes not identiWable with single polymorphisms (Ouma et al. 2008a, b) . As such, the role of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes in mediating susceptibility to SMA and functional changes in IFN-levels were examined in children with acute malaria (n = 528; 3-36 months) in a holoendemic P. falciparum transmission area of western Kenya. In addition, the relationship between the haplotypes, repeated episodes of SMA, and all-cause mortality were also investigated and we identiWed children (n = 528), who had complete data on malaria morbidity over a 3-year follow-up period, and included these in longitudinal analyses.
Methods

Study participants
Children with P. falciparum malaria were recruited at Siaya District Hospital (SDH), western Kenya. A total of 528 study participants were included in the current investigation for both the cross-sectional (acute malaria) and longitudinal analyses. In this holoendemic P. falciparum transmission area (Bloland et al. 1999b ), SMA and hyperparasitemia are the most common clinical manifestations of severe malaria, with CM occurring only in rare cases (Bloland et al. 1999a; Ong'echa et al. 2006) . Greater than 99% of the study participants were from the Luo ethnic group. Children with malaria were stratiWed into non-severe malarial anemia (non-SMA; Hb¸6.0 g/dL) and severe malarial anemia (SMA; Hb < 6.0 g/dL) groups (McElroy et al. 1999) . Administration of antimalarials and appropriate supportive therapy was provided for all children as per Kenya Ministry of Health guidelines. None of the children included in the study had non-falciparum parasitemia and/or CM. Written informed consent in the language of choice (i.e., English, Kiswahili, or Dholuo) was obtained from the parents/guardians of participating children. The study was approved by the Institutional Review Boards at the University of Pittsburgh and University of New Mexico, and the Kenya Medical Research Institute Ethical Review Board.
Laboratory procedures
Venous blood samples (<3.0 mL) were obtained prior to the administration of antimalarials and/or any other treatment interventions. Asexual malaria parasites (trophozoites) were counted against 300 leukocytes in peripheral blood smears stained with 3% Giemsa. Parasite density was estimated using the white blood cell (WBC) count/ L of each individual. Complete hematological parameters were determined with a Beckman Coulter ® AcT diV2™ (BeckmanCoulter Corporation). Presences of the sickle cell trait (HbAS), and Glucose-6-Phosphate Dehydrogenase (G6PD) deWciency, were determined as previously described (Ouma et al. 2010) . HIV-1 exposure and infection were determined by serological (i.e., Unigold™ and Determine™) and HIV-1 proviral DNA PCR testing, respectively, according to our previously published methods . Pre-and post-test HIV counseling was provided for all participants. Trimethoprim-sulfamethoxazole was administered to all children that were positive for one or both serological HIV-1 tests. At the time of the sample collection, none of the HIV-1(+) study participants had been initiated on antiretroviral treatment. Bacteremia was determined using Wampole™ Isostat ® Pediatric 1.5 system (Inverness Medical) and blood was processed according to the manufacturer's instructions. API biochemical galleries (bioMerieux, Inc.) and/or serology were used for the identiWcation of bacterial isolates as previously described (Were et al. 2011 ).
Genotyping
DNA was extracted from blood spotted on FTA ® Classic cards (Whatman Inc.) using the Chelex method (Vignoli et al. 1995 ). The genomic DNA was then ampliWed using a DNA AmpliWcation Kit via a strand displacement reaction (GE Healthcare). Fc RIIA-131H/R genotypes were determined using previously described methods by gene-speciWc PCR ampliWcation on a PTC-100™ thermocycler (MJ Research, Inc.) followed by allele-speciWc restriction enzyme digestion with BstUI (New England Biolabs) (Jiang et al. 1996) . BstUI digestion of the PCR product (366 bp) produced a 322-bp fragment for the RR131 genotype, a 343-bp fragment for the HH131 genotype, and both fragments for the HR131 genotype. Fc RIIIB-NA1/NA2 genotyping was carried out using allele-speciWc primers as previously described (Bux et al. 1995) .
Determination of circulating IFN-levels Plasma samples were obtained from venous blood and stored at ¡80°C until use. IFN-concentrations were determined using the Cytokine 25-plex Ab Bead Kit, Hu (BioSource™ International) according to the manufacturer's protocol. Plates were read on a Luminex 100™ system (Luminex Corporation) and analyzed using the Bio-plex Manager Software (Biorad Laboratories). The detection limit for IFN-was 5.0 pg/mL.
Longitudinal follow-up
Children presenting for their Wrst 'hospital contact' for treatment of febrile illnesses were enrolled into the SMA study at SDH (Day 0). Even though the study included children that were presenting at the Outpatient Department at SDH for routine vaccinations, these were not included in the current analyses. Parents/guardians were requested to return with their child every 3 months throughout the 3-year follow-up period. Since we determined the location of each child's residence with our GIS surveillance system, if the parent/guardian had not returned to hospital by 1:00 p.m. for the scheduled quarterly follow-up visit, our study staV visited the child's residence to check on their health status. In addition, since children experience multiple episodes of malaria, and other pediatric infectious diseases in this region, parents/guardians were requested to return to hospital during their child's febrile episode(s). At each acute and quarterly visit, all laboratory tests required for proper clinical management of the patients were performed, including complete hematological indices, malaria parasitemia determination, and evaluation of bacteremia (if clinically indicated). In addition, mortality data were collected throughout the 3-year follow-up. Mortality data, along with clinical and laboratory measures for multiple episodes of malaria, were used to evaluate the association between haplotypes and longitudinal outcomes of malaria and mortality.
Statistical analyses
Statistical analyses were performed using SPSS (Version 15.0). Chi-square analyses were used to examine diVerences between the proportions. Across-group comparisons of non-parametric data were determined by Kruskal-Wallis tests, while Mann-Whitney U tests were used for pairwise comparisons. Deviations from Hardy-Weinberg Equilibrium (HWE) were tested using the web-based site www.tufts.edu/»mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls. Haplotypes were constructed using the HPlus software program (Fred Hutchinson Cancer Research Center) and their frequencies estimated based on a Bayesian algorithm. For the cross-sectional analyses in children with acute malaria, the associations between the Fc R (Fc RIIA-131H/R and Fc RIIIB-NA1/NA2) haplotypes and SMA were determined by multivariate logistic regression, controlling for the potential confounding eVects of age, gender, HIV-1 status [including both HIV-1 exposed and deWnitively HIV-1(+) results], bacteremia, sickle cell trait (HbAS), and G6PD deWciency. Hierarchical logistic regression analyses were used for determining the longitudinal relationship between Fc R (Fc RIIA-131H/R and Fc RIIIB-NA1/NA2) haplotypes, SMA, and mortality. Covariates (i.e., age, gender, HIV-1 status, bacteremia, sickle cell trait, and G6PD deWciency) were entered into block 1 and the haplotype contrast (carrier vs. non-carrier) was entered into block 2. All values of P < 0.100 were further analyzed using Cox regression/survival analysis, and diVerences in the distributions of hazard rate functions (i.e., the probabilities of experiencing the event) between the carriers and non-carriers were examined using Mann-Whitney U tests. SigniWcance was set at P · 0.05.
Results
Demographic, clinical, and laboratory characteristics of the study participants upon enrollment Since we hypothesized that genetic variation in the Fc R gene (i.e., Fc RIIA-131H/R and Fc RIIIB-NA1/NA2) would condition disease severity, we Wrst performed cross-sectional analyses in children (aged <3-36 months, n = 528) presenting at hospital with acute P. falciparum malaria. Table 1 presents the demographic, clinical, and laboratory characteristics of the study participants stratiWed into non-severe malarial anemia (non-SMA; Hb¸6.0 g/dL; n = 298) and severe malarial anemia (SMA, Hb < 6.0 g/dL; n = 230). The distribution of gender was comparable between the two groups (P = 0.367). Upon presentation at hospital, children with SMA were younger than those with non-SMA (P < 0.001). Axillary temperature (°C) was also comparable between the groups (P = 0.144). As expected, based on the a priori grouping, Hb concentrations (g/dL) and red blood cell (RBC) counts (£10 12 /L) were lower in the SMA group (P < 0.001 for both comparisons). White blood cell (WBC) counts (£10 3 / L) were elevated in the SMA group (P < 0.001). Parasite density ( L) and the prevalence of high-density parasitemia (HDP, ¸10,000 parasites/ L) were comparable between the groups (P = 0.794 and P = 0.229, respectively).
Relationship between circulating IFN-and disease severity
Prior to investigating the inXuence of polymorphic variability in Fc R on SMA, the relationship between circulating IFN-and disease severity was determined in children with acute malaria. As shown in Fig. 1 Fig. 1 ], suggesting that high levels of circulating IFN-are associated with enhanced disease severity in this population of children. . Association between IFN-levels and disease severity in parasitemic children with SMA (n = 136) and non-SMA (n = 126). Boxes represent the interquartile range, the line through the box is the median, and whiskers show 10th and 90th percentiles. Statistical signiWcance was determined by the Mann-Whitney U test. Presence of SMA was signiWcantly associated with lower IFN-levels relative to non-SMA (P = 0.006)
Distribution of Fc R genotypes
After establishing that elevated circulating IFN-levels were signiWcantly higher in children with SMA, the distribution of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 genotypes was determined in the population. Genotypic distributions of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 variants in the non-SMA (n=298) and SMA (n=230) groups are presented in Table 2 . The prevalence of Fc RIIA-131H/ R genotypes in the population was 28.2% H/H, 46.4% H/R, and 25.4% R/R, with overall allele frequencies of 0.51 for 131H and 0.49 for 131R. There was no signiWcant departure from Hardy-Weinberg Equilibrium (HWE) in the overall cohort for Fc RIIA-131H/R ( 2 = 2.67, P = 0.101). The genotypic distribution of Fc RIIA-131H/R in the non-SMA group was 29.9% H/H, 46.3% H/R, and 23.8% R/R, yielding allele frequencies of 0.53 for 131H and 0.47 for 131R. The non-SMA group did not have signiWcant departure from HWE ( 2 = 1.47, P = 0.224) in the Fc RIIA-131H/R gene. Distributions of genotypes in the SMA group were 26.1% H/H, 46.5% H/R, and 27.4% R/R, with allele frequencies of 0.54 for 131H and 0.46 for 131R. The SMA also failed to display signiWcant departure from HWE ( 2 = 1.10, P = 0.292).
The prevalence of Fc RIIIB-NA1/NA2 genotypes in the population was 4.3% NA1/NA1, 65.3% NA1/NA2, and 30.4% NA2/NA2, with overall allele frequencies of 0.37 for NA1 and 0.63 for NA2. There was signiWcant departure from HWE in the overall cohort for Fc RIIIB-NA1/NA2 ( 2 = 84.96, P < 0.001). The genotypic distribution of Fc RIIIB-NA1/NA2 in the non-SMA group was 4.6% NA1/NA1, 62.8% NA1/NA2, and 32.6% NA2/NA2, yielding allele frequencies of 0.37 for NA1 and 0.63 for NA2. The non-SMA group had signiWcant departure from HWE ( 2 = 38.74, P < 0.001). Distributions of genotypes in the SMA group were 3.9% NA1/NA1, 68.7% NA1/NA2, and 27.4% NA2/NA2, with allele frequencies of 0.37 for NA1 and 0.63 for NA2. The SMA group also displayed signiWcant departure from HWE ( 2 = 47.42, P < 0.001). Further analysis revealed that the cross-sectional distribution of the Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 genotypes was comparable between the non-SMA and SMA groups (P = 0.520 and P = 0.363, respectively) ( Table 2) .
Cross-sectional distribution of Fc R haplotypes Construction of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes revealed the following prevalence: Fc RIIA-131H/Fc RIIIB-NA1, 52.4% (277/528); Fc RIIA-131H/ Fc RIIIB-NA2, 41.0% (217/528); Fc RIIA-131R/Fc RI-IIB-NA1, 19.1% (101/528), and Fc RIIA-131R/Fc RIIIB-NA2, 69.1% (365/528). The distributions of haplotypes in the non-SMA and SMA groups are shown in Table 3 . Although none of the haplotypic distributions were signiWcantly diVerent between the two clinical groups, there was a trend toward greater carriage of the Fc RIIA-131R/Fc RI-IIB-NA2 haplotype in children with SMA (P = 0.077). Data are presented as proportions (n, %) SMA, severe malarial anemia (Hb < 6.0 g/dL with any density parasitemia) (McElroy et al. 1999) , Non-SMA non-severe malarial anemia (Hb¸6.0 g/dL with any density parasitemia). P(C) frequency of wildtype allele in the population a Statistical signiWcance determined by Chi-square analysis. In the cross-sectional analysis, the distribution of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 genotypes was comparable between the two groups Association between Fc R haplotypes and SMA in children with acute malaria
To determine the role of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes in conditioning susceptibility to SMA, multivariate logistic regression analyses were conducted while controlling for the potential confounding eVects of age, gender, HIV-1 status, bacteremia, sickle-cell trait and G6PD deWciency (Aidoo et al. 2002; Berkley et al. 1999; Otieno et al. 2006; Wambua et al. 2006a, b) . As shown in Table 4 , although none of the haplotypes were signiWcantly associated with susceptibility to SMA, the Fc RIIA-131H/Fc RIIIB-NA1 haplotype showed a trend toward a protective eVect (OR 0.83, 95% CI 0.72-1.06; P = 0.088), while carriage of the Fc RIIA-131R/Fc RIIIB-NA2 haplotype was associated with enhanced risk of SMA (OR 1.44, 95% CI 0.97-2.13; P = 0.071).
Longitudinal distribution of Fc R haplotypes
Construction of Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes in those with SMA in the longitudinal follow-up revealed the following prevalence: Fc RIIA-131H/Fc RI-IIB-NA1, 38.5%; Fc RIIA-131H/Fc RIIIB-NA2, 69.7%; Fc RIIA-131R/Fc RIIIB-NA1, 60.3%, and Fc RIIA-131R/ Fc RIIIB-NA2, 45.4%.
Relationship between Fc R haplotypes and longitudinal outcomes
After determining the association between the haplotypes and susceptibility to SMA in children with acute malaria, we examined the relationship between carriage of the diVerent haplotypes and longitudinal outcomes (i.e., repeated episodes of SMA and mortality) over a 3-year follow-up period. Hierarchical logistic regression analyses, controlling for age, gender, HIV-1 status, bacteremia, sickle cell trait and G6PD deWciency demonstrated that carriage of the Fc RIIA-131H/Fc RIIIB-NA1 haplotype was associated with a 35% reduced risk of developing SMA (RR 0.65, 95% CI 0.46-0.90; P = 0.012). In contrast, carriage of the Fc RIIA-131H/Fc RIIIB-NA2 haplotype was associated with an increased risk of SMA (RR 1.47, 95% CI 1.06-2.04; P = 0.020; Table 5 ). Given that heterozygous individuals can have a diluting eVect on haplotypes, we constructed additional haplotypes based on homozygosity on the two loci (i.e., Fc RIIA-131H/H/Fc RIIIB-NA1/NA1 and Fc RIIA-131H/H/Fc RIIIB-NA2/NA2) for the haplotypes that demonstrated signiWcant associations with SMA. Consistent with our earlier observation, this model demonstrated that the Fc RIIA-131H/H/Fc RIIIB-NA1/NA1 was associated with reduced risk to SMA (RR 0.45, 95% CI 0.37-0.74; P = 0.007) while carriage of Fc RIIA-131H/H/ Fc RIIIB-NA2/NA2 was associated with an increased risk of SMA (RR 1.64, 95% CI 1.10-2.17; P = 0.016). Furthermore, haplotypes were constructed for individuals both heterozygous at Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 loci. Results revealed that the presence of heterozygosity at these two loci was associated with protection against SMA (RR 0.72, 95% CI 0.48-0.93; P = 0.037) relative to those nonheterozygous, thus masking the increased susceptibility associated with Fc RIIA-131H/Fc RIIIB-NA2 haplotype.
Longitudinal analyses revealed that non-carriers of the 131H/NA1 haplotype had an increased risk to mortality relative to carriers. Consistent with these results, Cox regression modeling (controlling for covariates) revealed a higher risk of all-cause mortality in non-carriers of the 131H/NA1 haplotypes relative to carriers (P = 0.002). The mortality Table 4 Relationship between Fc RIIA-131H/R and Fc RIIIB-NA1/ NA2 haplotypes and susceptibility to SMA in children with acute malaria Children with acute malaria (n = 528) were categorized according to a modiWed deWnition of SMA based on age-and geographically-matched Hb concentrations (i.e., Hb <6 .0 g/dL, with any density parasitemia) (McElroy et al. 1999) . Odds Ratios (OR) and 95% conWdence intervals (CI) were determined using multivariate logistic regression controlling for age, gender, HIV-1 status, bacteremia, sickle cell trait (HbAS) and G6PD deWciency. The reference groups in the multivariate logistic regression analyses were those without the respective haplotypes Table 5 Relationship between Fc R haplotypes and susceptibility to SMA over a 3-year follow-up period Children (n = 528) were followed longitudinally for three years from their date of enrollment. The deWnition of SMA was based on age-and geographically matched Hb concentrations (i.e., Hb < 6.0 g/dL, with any density parasitemia) (McElroy et al. 1999 Fig. 2 ]. Circulating IFN-levels were comparable between the carriers of the Fc RIIA-131H/Fc RIIIB-NA2 (131H/NA2) (P = 0.551), Fc RIIA-131R/Fc RIIIB-NA2 (131R/NA2) (P = 0.708), and their respective non-carriers ( 
Discussion
In the current study, we tested the hypothesis that haplotypes in Fc R genes (i.e., Fc RIIA-131H/R and Fc RIIIB-NA1/NA2) could alter susceptibility to SMA in children resident in a P. falciparum holoendemic transmission region of western Kenya. In addition, we explored whether or not these haplotypes were associated with functionality in production of IFN-. Cross-sectional analyses in children with acute malaria showed that the Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes did not signiWcantly inXuence susceptibility to SMA. However, longitudinal analyses over a 3-year follow-up period demonstrated that carriage of the Fc RIIA-131H/Fc RIIIB-NA1 haplotype was associated with 35% reduction in the development of SMA, while the presence of Fc RIIA-131H/Fc RIIIB-NA2 haplotype increased the risk of SMA. In addition, Cox regression modeling of the follow-up data revealed a higher risk of all-cause mortality in non-carriers of the Fc RIIA-131H/Fc RIIIB-NA1 haplotypes relative to carriers. Measurement of circulating IFN-showed that the 'protective' Fc RIIA-131H/Fc RIIIB-NA1 haplotype was also associated with decreased IFN-production. To our knowledge, this is the Wrst report delineating the associations between Fc RIIA-131H/R and Fc RIIIB-NA1/NA2 haplotypes, SMA (Hb < 6.0 g/dL), and mortality in holoendemic P. falciparum transmission areas, such as western Kenya. Pertinent to our observations was the fact that there were no associations between the haplotypes and SMA in the crosssectional analyses performed in children with acute malaria, while the same haplotypes predicted susceptibility to SMA (and mortality) over a 3-year longitudinal followup, underscoring the importance of using longitudinal data in disease association studies. Previous cross-sectional analyses in a large cohort in The Gambia revealed that the Fc RIIA-H/H131 genotype was associated with increased malaria disease severity, particularly in children less than 5 years of age (Cooke et al. 2003) . Although severe malaria in this population was deWned by a mixed phenotype of disease (CM, SMA, and/or hypoglycemia), the Fc RIIA-H/H131 genotype was more prevalent in those with SMA compared with aparasitemic children (Cooke et al. 2003) . Other studies, carried out in Gedaref State in the Daraweesh population (aged 2-55 years) of eastern Sudan, demonstrated that the Fc RIIA-H/H131 genotype was more prevalent in the Fulani (who Fig. 2 Functional association between Fc RIIA-131H/R and Fc RI-IIB-NA1/NA2 haplotypes and IFN-. Circulating IFN-levels were measured using ELISA. Data are shown for the Fc RIIA-131H/Fc RI-IIB-NA1 (n = 130), Fc RIIA-131H/Fc RIIIB-NA2 (n = 108), Fc RI-IA-131R/Fc RIIIB-NA1 (n = 50) and Fc RIIA-131R/Fc RIIIB-NA2 (n = 185) haplotypes. Fc RIIA-131H/Fc RIIIB-NA1 = 131H/NA1 on the Wgure. Data are presented as box-plots, where the box represents the interquartile range, the line through the box is the median, and whiskers show the 10th and 90th percentiles. Pairwise comparisons in those with haplotype versus those without haplotypes were determined by MannWhitney U tests. Presence of the 131H/NA1 was associated with signiWcantly lower circulating IFN-levels relative to individuals without the haplotype. In addition, even though the presence of 131R/NA1 was associated with higher production of IFN-levels relative to individuals without the haplotype, it was at borderline signiWcance (P = 0.067). Shaded boxes represent presence of haplotype while open boxes represents non-haplotypes are less aVected by clinical malaria) than in sympatric nonFulani ethnic groups (Nasr et al. 2007) . Additional studies demonstrated an association between the R/R131 genotype and susceptibility to severe malaria in Sudanese patients presenting with a mixed clinical phenotype (Nasr et al. 2007) , while in an Indian population, the Fc RIIA-H/H131 genotype was signiWcantly associated with protection from malaria in individuals over 5 years of age with a diverse phenotypic deWnition of disease (CM and/or severe anemia, acidotic breathing, pulmonary edema, hypoglycemia or increased serum creatinine levels) (Sinha et al. 2008) . Our previous studies ) and those of others in adjacent areas of western Kenya (Shi et al. 2001) in children with malaria demonstrated that the Fc RIIA-R/R131 genotype was associated with protection against HDP and lower thresholds of parasitemia. A previous cross-sectional study in Thai adults showed that the Fc RIIA-H/H131 genotype, together with the Fc RIIIB-NA2 allele, was associated with increased susceptibility to CM (Omi et al. 2002) . Our haplotypic Wndings demonstrated that carriage of the Fc RIIA-131H/Fc RIIIB-NA1 haplotype was associated with a reduced risk of SMA, while carriers of the Fc RIIA-131H/Fc RIIIB-NA2 haplotype had an increased risk of developing SMA. Reasons for diVerences in results presented here versus previous Wndings may be related to the following: (a) there are likely diverse immunoprotective responses to malaria conditioned by diVerent exposure rates (i.e., hyper-vs. holoendemic); (b) since CM is a rare manifestation of severe malaria in our cohort and most of the previous studies included this disease phenotype, the potentially powerful eVects of the Fc R genotypes on CM cannot be observed in a population in which the primary clinical outcome of severe malaria is SMA; and c) previous studies focused on single polymorphisms, while in the current study, we investigated the associations between haplotypes and susceptibility to SMA. Results presented here underscore the fact that multi-site haplotypes are highly informative allelic markers that can reveal associations with disease outcomes not identiWable with single polymorphisms (Ouma et al. 2008a, b) .
Fc Rs on macrophages/monocytes play an important role in the pathogenesis of severe malaria by mediating phagocytosis of both infected and uninfected RBCs and by triggering the production of pro-inXammatory cytokines. For example, previous studies demonstrated that TNFsecretion by these cell populations varied considerably among individuals after Fc R cross-linking (Debets et al. 1988) . Additional analyses demonstrated that clearance half-lives of IgG-sensitized RBCs varied in patients presenting with acute P. falciparum malaria and was directly correlated with hematocrit values (Ho et al. 1990; Lee et al. 1989) , implying that Fc R-mediated clearance of uninfected erythrocytes may be important in the development of SMA. These observations, coupled with Wndings showing heterogeneity of responses to stimulatory signals among monocytes from diVerent individuals, suggest that individuals with responses that lead to enhanced erythrophagocytic activity and/or production of high levels of TNF-may be predisposed to SMA (Ogonda et al. 2010 ). We present Wndings in the current study showing that Fc RIIA-131H/ Fc RIIIB-NA1 haplotype was associated with a decreased risk of SMA, while carriage of Fc RIIA-131H/Fc RIIIB-NA2 haplotype increased the risk of SMA during a 3-year follow-up period. Additional investigation of the relationship between Fc R haplotypes and susceptibility to mortality over the 3-year follow-up demonstrated that noncarriers of Fc RIIA-131H/Fc RIIIB-NA1 haplotype had a higher risk of all-cause mortality relative to carriers. This observation is consistent with the fact that carriers of the Fc RIIA-131H/Fc RIIIB-NA1 haplotype had a signiWcantly reduced risk of SMA over the same period. These results further illustrate that the same Fc R haplotypes that are important for conditioning susceptibility to repeated episodes of SMA also inXuence the risk of mortality during the critical phases in which naturally acquired malarial immunity is developing.
There is accumulating evidence about the role of IFNin the control of infectious diseases. Earlier studies carried out in a malaria endemic region of Ghana demonstrated that production of malaria-speciWc IFN-was associated with the reduced risk of fever and clinical malaria (Dodoo et al. 2002) . Additional studies revealed that in cases of uncomplicated malaria, activated CD8 T cells produce IFNthrough macrophage activation (Torre et al. 2002b ), a process that may be important in limiting parasite expansion and, thereby preventing disease progression toward severe, life-threatening malaria (Torre et al. 2002a) . Recent studies in Nigerian children less than 6 months of age showed higher levels of IFN-in symptomatic children relative to non-symptomatic controls, with the interpretation that elevated IFN-levels were instrumental in immune-mediated protection against malaria by limiting parasite replication (Iriemenam et al. 2009 ). Exposure to IFN-in a variety of tissues and cells signiWcantly increases the transcriptional (or post-transcriptional) expression of several major histocompatibility complex (MHC) class I genes, including Fc R (Colgan et al. 1996; Gobin et al. 1999; Lefebvre et al. 1999; Yang et al. 1996) . Elevated expression of Fc R can further augment binding of cytophilic immunoglobulins leading to enhanced phagocytosis by monocytes/macrophages. Although collectively these studies illustrate the importance IFN-in controlling parasitemia, the precise role of IFN-in the pathogenesis of SMA remains elusive. For example, in the current study, we demonstrate that children with SMA had signiWcantly higher circulating IFN-levels, and that the Fc RIIA-131H/Fc RIIIB-NA1 haplotype, which protected against SMA, was characterized by signiWcantly lower IFN-production. Increased IFN-production can promote elevated TNF-levels (Urban et al. 2005) which have been shown to enhance the pathogenesis of SMA (Kurtzhals et al. 1999; Luty et al. 2000; McDevitt et al. 2004; Othoro et al. 1999; Prakash et al. 2006 ). As such, although not explored in the current study, it is hypothesized that lower IFN-levels in children with Fc RIIA-131H/Fc RIIIB-NA1 haplotype may prevent overproduction of TNF-, thereby leading to a decreased risk for development of SMA.
Studies show an inverse correlation between IFN-and parasite density supporting the notion that IFN-plays a protective role against parasitemia (D'Ombrain et al. 2008; McCall et al. 2010; Pombo et al. 2002; Walther et al. 2006) . However, it is important to note that childhood SMA in holoendemic transmission regions is typically not deWned by higher levels of peripheral parasitemia . We hypothesize that elevated levels of IFNare important for controlling parasitemia during the early phases of infection, but that persistently high levels, and/or the inappropriate timing of IFN-release (conditioned by genetic variation) may promote pathological consequences, such as SMA. Although conWrmation of this hypothesis will require a time-series analysis of a panel of immune mediators (IFN-included) during diVerent phases of the immune response to malaria in individuals stratiWed according to haplotypic groups, previous studies demonstrated that generation of pro-inXammatory cytokines that control malaria parasitemia may also contribute to the immunopathology of disease (Artavanis-Tsakonas et al. 2003) .
In conclusion, we show that the reduced susceptibility to repeated episodes of SMA and mortality over the critical time periods in which naturally acquired immunity to malaria is developing is associated with haplotypes in the Fc R gene which produce lower levels of IFN-responses. Future studies aimed at further deWning how genetic variation conditions IFN-responses may aid in deWning important correlates of protection against SMA that can be used in vaccine development and testing.
